Comments
Loading...

Cardiol Therapeutics Analyst Ratings

CRDLNASDAQ
Logo brought to you by Benzinga Data
Consensus Rating1
Buy
Highest Price Target1
$10.00
Lowest Price Target1
$3.00
Consensus Price Target1
$7.50

Cardiol Therapeutics Analyst Ratings and Price Targets | NASDAQ:CRDL | Benzinga

Cardiol Therapeutics Inc has a consensus price target of $7.5 based on the ratings of 4 analysts. The high is $10 issued by Roth MKM on June 26, 2024. The low is $3 issued by Cantor Fitzgerald on August 14, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on February 24, 2025, December 18, 2024, and November 20, 2024, respectively. With an average price target of $9 between HC Wainwright & Co., there's an implied 631.71% upside for Cardiol Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Oct 24
1
Nov 24
1
Dec 24
1
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Roth MKM
Canaccord Genuity
Cantor Fitzgerald

1calculated from analyst ratings

Analyst Ratings for Cardiol Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Cardiol Therapeutics (CRDL) stock?

A

The latest price target for Cardiol Therapeutics (NASDAQ:CRDL) was reported by HC Wainwright & Co. on February 24, 2025. The analyst firm set a price target for $9.00 expecting CRDL to rise to within 12 months (a possible 631.71% upside). 10 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cardiol Therapeutics (CRDL)?

A

The latest analyst rating for Cardiol Therapeutics (NASDAQ:CRDL) was provided by HC Wainwright & Co., and Cardiol Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Cardiol Therapeutics (CRDL)?

A

There is no last upgrade for Cardiol Therapeutics

Q

When was the last downgrade for Cardiol Therapeutics (CRDL)?

A

There is no last downgrade for Cardiol Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Cardiol Therapeutics (CRDL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cardiol Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cardiol Therapeutics was filed on February 24, 2025 so you should expect the next rating to be made available sometime around February 24, 2026.

Q

Is the Analyst Rating Cardiol Therapeutics (CRDL) correct?

A

While ratings are subjective and will change, the latest Cardiol Therapeutics (CRDL) rating was a reiterated with a price target of $9.00 to $9.00. The current price Cardiol Therapeutics (CRDL) is trading at is $1.23, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.